Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
10 June 2003
This message informs health professionals about new evidence relating to the efficacy and safety of Seroxat (paroxetine) in children and adolescents under the age of 18 years when used to treat depressive illness. The CSM advises that Seroxat should not be used in children and adolescents under the age of 18 years to treat depressive illness.
